Driehaus Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3M | Buy |
223,280
+9,141
| +4% | +$954K | 0.19% | 161 |
|
|
2025
Q1 | $25M | Buy |
+214,139
| New | +$25M | 0.24% | 128 |
|
|
2024
Q2 | – | Sell |
-204,699
| Closed | -$16.3M | – | 371 |
|
|
2024
Q1 | $16.3M | Sell |
204,699
-61,143
| -23% | -$4.88M | 0.16% | 184 |
|
|
2023
Q4 | $21.2M | Buy |
265,842
+16,953
| +7% | +$1.35M | 0.25% | 127 |
|
|
2023
Q3 | $17.4M | Buy |
248,889
+117
| +0% | +$8.18K | 0.23% | 149 |
|
|
2023
Q2 | $17.9M | Buy |
248,772
+82,267
| +49% | +$5.91M | 0.23% | 143 |
|
|
2023
Q1 | $10.3M | Sell |
166,505
-66,590
| -29% | -$4.11M | 0.14% | 216 |
|
|
2022
Q4 | $18M | Buy |
+233,095
| New | +$18M | 0.27% | 127 |
|
|
2020
Q3 | – | Sell |
-241,284
| Closed | -$19.9M | – | 392 |
|
|
2020
Q2 | $19.9M | Sell |
241,284
-21,257
| -8% | -$1.75M | 0.48% | 60 |
|
|
2020
Q1 | $15.4M | Sell |
262,541
-13,176
| -5% | -$775K | 0.52% | 56 |
|
|
2019
Q4 | $28.5M | Buy |
+275,717
| New | +$28.5M | 0.76% | 26 |
|